Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Section Navigation
			
			CDC Home


Facebook
        Twitter
        LinkedIn
        Syndicate





Prescription Opioid and Benzodiazepine Medications and Occupational Safety and Health										Related Pages
					May 2021
DHHS (NIOSH) Publication Number 2021-116
Thumbnail image of 2021-116 doc
Prescription opioid medications intended for pain management and prescription benzodiazepines for conditions such as anxiety or insomnia, when used alone or together, often have side effects that can affect workers’ health and safety. In addition, some occupational factors, such as work-related motor vehicle crashes, falls, other injuries and job stress, have the potential to increase the chances that a worker is given a prescription for an opioid or benzodiazepine [Kowalski-McGraw et al. 2017].
The Centers for Disease Control and Prevention (CDC) has developed resources for improving communication between clinicians and patients about the risks and benefits of opioid therapy for pain, improving the safety and effectiveness of pain treatment, and reducing the risks associated with long-term opioid therapy, including opioid use disorder (a problematic pattern of opioid use that causes significant impairment or distress), overdose, and death. In some cases, prescriptions could be an initial or single one. In other cases, an opioid and/or benzodiazepine prescription could be the starting point for increasing and/or long term use.
This fact sheet summarizes findings from the scientific literature [Kowalski-McGraw et al. 2017] and provides information from relevant CDC and National Institute for Occupational Safety and Health (NIOSH) publications for employers and healthcare providers about the prescription use of opioids and benzodiazepines.

**Prescription Opioid and Benzodiazepine Medications and Occupational Safety and Health**pdf icon[PDF – 230 KB]
Suggested Citation
NIOSH [2021]. Prescription opioid and benzodiazepine medications and occupational safety and health: information for employers and healthcare providers. By Pandalai SP, Schulte PA, Afanuh SE. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2021–116. https://doi.org/10.26616/NIOSHPUB2021116external icon
							
					
						Page last reviewed:  May 6, 2021										Content source: 	National Institute for Occupational Safety and Health homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue